Hermetica Superfood Encyclopedia
The Short Answer
Nux vomica contains strychnine and brucine as primary alkaloids that affect the central nervous system by blocking glycine and GABA receptors. This Ayurvedic seed extract has been traditionally used for neurological conditions, though clinical evidence remains extremely limited.
CategoryHerbs (Global Traditional)
GroupAyurveda
Evidence LevelModerate
Primary Keywordnux vomica benefits
Synergy Pairings3
Nux Vomica (Strychnos nux-vomica) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Nux Vomica derives from the dried ripe seeds of the Strychnos nux-vomica L. tree (family Loganiaceae), an evergreen species native to Southeast Asia. The seeds are typically processed through traditional methods like decoction or compatibility with other herbs to reduce toxicity of the main alkaloids strychnine and brucine.
“In Traditional Chinese Medicine, Nux Vomica has been used for treating ischemic stroke, neurodisorders, arthritis, and rheumatism through its actions of dredging collaterals and relieving pain. Unani medicine traditionally uses the seeds (Azraqi) to elevate blood pressure, while Southeast Asian traditions employed it for various symptoms including indigestion and nausea.”Traditional Medicine
Scientific Research
No human clinical trials, RCTs, or meta-analyses on Nux Vomica exist in the current research. Evidence is limited to animal models including a rat spinal cord injury study (PMID: 32527244) showing sensory/motor recovery, and toxicity studies in rats (n=36) demonstrating metabolic disruptions at 0.315-0.630 g/kg doses. Network pharmacology predictions suggest 14 active compounds targeting 59 genes relevant to ischemic stroke, but human validation is absent.
Preparation & Dosage
Traditional preparation
No clinically studied human dosage ranges are available. Animal toxicity studies used 0.315-0.630 g/kg body weight orally in rats (decoction form), which caused organ damage. Traditional use emphasizes strict control of strychnine/brucine content via processing, but no standardized extract dosages are specified. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
{"macronutrients": {"protein": "Approximately 5-10% of dry weight", "fiber": "Approximately 10-15% of dry weight"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts"}, "minerals": {"Calcium": "Approximately 200-250 mg per 100g", "Magnesium": "Approximately 100-150 mg per 100g", "Iron": "Approximately 5-10 mg per 100g"}}, "bioactive_compounds": {"Strychnine": "Approximately 1-2% of dry weight", "Brucine": "Approximately 0.5-1% of dry weight"}, "bioavailability_notes": "Strychnine and brucine are highly toxic alkaloids with limited therapeutic window. Nutrient bioavailability may vary based on preparation and individual health conditions."}
How It Works
Mechanism of Action
Strychnine, the primary alkaloid in nux vomica, acts as a competitive antagonist of glycine receptors in the spinal cord and brainstem. This blockade prevents inhibitory neurotransmission, leading to increased neuronal excitability. Brucine, the secondary alkaloid, has similar but weaker glycine receptor antagonist properties and may modulate calcium channels and serotonergic pathways.
Clinical Evidence
Clinical evidence for nux vomica is extremely limited and largely theoretical. One animal study (PMID: 32527244) suggested potential benefits for spinal cord injury recovery in rats, but no human clinical trials exist. Traditional Ayurvedic literature describes use for stroke management through multi-pathway mechanisms, but this lacks scientific validation. The evidence base consists primarily of preclinical research and traditional use reports rather than controlled human studies.
Safety & Interactions
Nux vomica is extremely toxic due to strychnine content, with therapeutic doses dangerously close to lethal amounts. Strychnine poisoning causes violent muscle spasms, convulsions, and respiratory failure. It may interact with medications affecting GABA or glycine neurotransmission, including benzodiazepines and muscle relaxants. Pregnant and breastfeeding women should absolutely avoid nux vomica due to severe toxicity risks to both mother and child.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is the active compound in nux vomica?
The primary active compound is strychnine, a highly toxic alkaloid that blocks glycine receptors in the nervous system. Brucine is the secondary alkaloid with similar but weaker effects.
Is nux vomica safe to take as a supplement?
Nux vomica is extremely dangerous due to strychnine toxicity, with therapeutic doses very close to lethal amounts. It can cause severe muscle spasms, convulsions, and death, making it unsuitable for supplementation.
What conditions has nux vomica been used for traditionally?
Traditional Ayurvedic medicine has used nux vomica for neurological conditions including stroke management and nervous system disorders. However, these uses lack scientific validation and carry serious safety risks.
Are there any clinical studies on nux vomica benefits?
Clinical evidence is extremely limited, with only one animal study suggesting potential spinal cord injury benefits. No controlled human trials exist to support therapeutic use of nux vomica.
Can nux vomica interact with medications?
Yes, nux vomica may dangerously interact with medications affecting GABA or glycine neurotransmission, including benzodiazepines and muscle relaxants. The strychnine content makes any interactions potentially life-threatening.
What is the difference between nux vomica and other strychnine-containing herbs?
Nux vomica (Strychnos nux-vomica) is the primary commercial source of strychnine alkaloids, though strychnine is also found in other Strychnos species. The concentration and ratio of strychnine to other alkaloids like brucine varies between species and plant parts, which affects both potency and safety profiles. Most clinical and traditional preparations use seeds from Strychnos nux-vomica specifically due to standardized alkaloid content.
Who should avoid nux vomica supplementation?
Pregnant and nursing women should avoid nux vomica due to its neurotoxic alkaloids and lack of safety data in these populations. People with seizure disorders, cardiac arrhythmias, or severe kidney or liver disease should not use nux vomica without medical supervision, as strychnine can exacerbate these conditions. Individuals taking CNS-active medications, anticoagulants, or those with hypersensitivity to alkaloids should consult a healthcare provider before use.
How does nux vomica's mechanism of action relate to its traditional uses?
Nux vomica's strychnine acts as a glycine receptor antagonist and modulates serotonergic pathways, which theoretically supports its traditional use in neurological conditions like spinal cord injury and stroke recovery. Its proposed anti-inflammatory effects through COX-2 pathway modulation may contribute to pain relief and recovery support in traditional medicine systems. However, most mechanistic evidence remains in vitro or animal-based, and clinical translation of these pathways in humans is not yet established.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w nux-vomica curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
